This early work implied that RelA T505 phosphorylation could lead to a tumour suppressing form of NF-κB in some contexts, which again contrasted with the more usual tumour-promoting activity ascribed to this pathway [4,6]. The gene discussed is NFKB1; the disease is neoplasm.